Antibody-evading virus vectors
US12060390B2 · kind B2 · utility
0Cited by
120References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2023 |
| Grant date | Aug 13, 2024 |
| Priority date | — |
| Expiry date | Sep 26, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The disclosure also provides methods of administering the virus vectors and virus capsids of the disclosure to a cell or to a subject in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.